ANXA4 and neoplasm: Annexin 4-depleted cells showed a slight but not significant tumor reduction compared to controls, while a higher reduction was observed in Annexin 4-depleted xenografts treated with paclitaxel versus xenografts treated with paclitaxel alone (70% and 50%, respectively).